HT942523D0018 modification notice of intent
Closed Special Notice Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- HT942523D0018
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- 21702
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Medical Research Acquisition Activity (USAMRAA), operating under the Defense Health Agency, has issued a Notice of Intent regarding a sole source modification to existing contract HT942523D0018 on behalf of The U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID). The original contract was awarded to Trillamed LLC on September 22, 2023, following a full and open competitive process where Trillamed was the only offeror. This special notice fulfills the synopsis requirements under Federal Acquisition Regulation 5.2 and serves as formal notification of the government's intent to proceed with a sole source modification. The contract involves specialized biocontainment equipment for infectious disease research facilities. The notice emphasizes that this is not a request for quotations and no solicitation document currently exists.
The primary objectives of this contract modification are to replace biocontainment sterilizer units, including removal and disposal of existing equipment, installation of new units with biocontainment bioseal, certification and validation, and to upgrade software operating controls of existing pass-through biocontainment autoclaves. While the government intends to proceed on a sole source basis, vendors may challenge this approach by submitting capability statements that demonstrate their ability to provide these specialized supplies with convincing evidence and sufficient detail. Capability statements must be submitted via email only as Microsoft Word or Adobe PDF attachments to specified government email addresses by 1300 Eastern Time on August 10, 2025. The government reserves sole discretion in determining whether to proceed with competitive procurement based on any responses received. Requests for additional information or submissions containing only questions will not be considered valid responses to this notice.
Notice text
2 versions
Update #2 · Latest ·
Request for Information: The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends award on a sole source basis a modification to existing contract HT942523D0018 on behalf of The U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID). Contract HT942523D0018 was awarded to Trillamed LLC. on 22 September 2023. The objectives of this IDIQ are to (1) replace biocontainment sterilizer unit(s) (to include removal and disposal of existing units as well as installation of new units with biocontainment bioseal, certification and validation) and (2) upgrade software operating controls of existing pass-through biocontainment autoclaves. Trillamed was the only offer received during the full and open competitive commercial requirement. This announcement fulfills the synopsis requirements under FAR 5.2. This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these supplies. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Capability statements are due no later than 1300 Eastern Time, 10 August 2025. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email address Kirstin.L.Quinn.civ@health.mil and Emily.k.ohara.civ@health.mil No phone calls will be accepted.
Update #1 ·
NOTICE OF INTENTThe U.S. Army Medical Research Acquisition Activity (USAMRAA) intends award on a sole source basis a modification to existing contract HT942523D0018 on behalf of The U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID). Contract HT942523D0018 was awarded to Trillamed LLC. on 22 September 2023. The objectives of this IDIQ are to (1) replace biocontainment sterilizer unit(s) (to include removal and disposal of existing units as well as installation of new units with biocontainment bioseal, certification and validation) and (2) upgrade software operating controls of existing pass-through biocontainment autoclaves. Trillamed was the only offer received during the full and open competitive commercial requirement. This announcement fulfills the synopsis requirements under FAR 5.2. This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these supplies. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement.Capability statements are due no later than 1300 Eastern Time, 10 August 2025. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email address Kirstin.L.Quinn.civ@health.mil and Emily.k.ohara.civ@health.mil No phone calls will be accepted.
Notice history
| Notice | Type | Posted |
|---|---|---|
| HT942523D0018 modification notice of intent | Pre-Solicitation | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk | — | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| This is a notice of intent to issue a sole source contract | Defense Threat Reduction Agency | No set-aside | |
| Independent Commissioning Agent (Owner’s Advocate) Services for U. S. Army Medical Research Institute of Infectious Diseases | Defense Health Agency | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity